Edition:
United Kingdom

Aptose Biosciences Inc (APTO.OQ)

APTO.OQ on NASDAQ Stock Exchange Capital Market

1.83USD
18 Apr 2019
Change (% chg)

$-0.02 (-1.08%)
Prev Close
$1.85
Open
$1.84
Day's High
$1.86
Day's Low
$1.83
Volume
14,617
Avg. Vol
35,217
52-wk High
$4.55
52-wk Low
$1.58

About

Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates... (more)

Overall

Beta: 1.60
Market Cap(Mil.): $74.78
Shares Outstanding(Mil.): 40.25
Dividend: --
Yield (%): --

Financials

  APTO.OQ Industry Sector
P/E (TTM): -- 106.23 59.19
EPS (TTM): -0.86 -- --
ROI: -237.76 7.96 11.77
ROE: -237.76 8.09 12.61

Earnings vs. Estimates